A detailed history of Rafferty Asset Management, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 149,739 shares of AZN stock, worth $9.46 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
149,739
Previous 157,506 4.93%
Holding current value
$9.46 Million
Previous $12.3 Million 5.02%
% of portfolio
0.04%
Previous 0.05%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$76.67 - $87.62 $595,495 - $680,544
-7,767 Reduced 4.93%
149,739 $11.7 Million
Q2 2024

Aug 13, 2024

SELL
$66.81 - $80.83 $2.02 Million - $2.45 Million
-30,309 Reduced 16.14%
157,506 $12.3 Million
Q1 2024

May 13, 2024

BUY
$61.03 - $69.57 $1.27 Million - $1.45 Million
20,856 Added 12.49%
187,815 $12.7 Million
Q4 2023

Feb 13, 2024

BUY
$61.89 - $69.28 $2.69 Million - $3.01 Million
43,464 Added 35.19%
166,959 $11.2 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $1.85 Million - $2.05 Million
28,583 Added 30.12%
123,495 $8.36 Million
Q2 2023

Aug 11, 2023

BUY
$69.91 - $75.81 $1.08 Million - $1.18 Million
15,501 Added 19.52%
94,912 $6.79 Million
Q1 2023

May 11, 2023

BUY
$63.15 - $71.6 $879,174 - $996,815
13,922 Added 21.26%
79,411 $5.51 Million
Q4 2022

Feb 13, 2023

SELL
$54.21 - $70.44 $2.73 Million - $3.55 Million
-50,441 Reduced 43.51%
65,489 $4.44 Million
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $544,621 - $1.39 Million
10,272 Added 9.72%
115,930 $6.36 Million
Q2 2022

Aug 12, 2022

BUY
$59.26 - $71.14 $65,600 - $78,751
1,107 Added 1.06%
105,658 $6.98 Million
Q1 2022

May 13, 2022

BUY
$55.72 - $67.12 $5.83 Million - $7.02 Million
104,551 New
104,551 $6.94 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $196B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.